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CHAPTER III 
 
MATERIAL AND METHODS 
 
3.1 Sample collection and dissection 
Live adult prawns (M.rosenbergii, average body weight 25 g) were obtained 
from a hatchery at Jelebu, Negeri Sembilan, Malaysia whereas the sub-adult prawns 
which were used for IHHNV challenge study (M.rosenbergii, average body weight 10g, 
Section 3.16) were obtained from a hatchery at Bandar Sri Sedayan, Negeri Sembilan, 
Malaysia. The adult prawns were transported in transparent plastic bags with aerated 
freshwater. The organs were obtained from approximately 80 adult individuals, 
processed in batches of 20. Organs which included hepatopancreas, gill, muscle, eyestalk 
and pleopod tissues were immediately dissected and wrapped with aluminum foil. 
Thereafter, the sampled organs were directly frozen in liquid nitrogen before being 
packed in zip-lock bags and stored at -80°C prior to total RNA and genomic DNA 
extraction (Figure 3.1). The process of dissecting, freezing and storing were done rapidly 
to reduce the degradation of RNAs in the sampled organs.  
 
3.2 DNA extraction 
DNA extraction using DNeasy Blood and Tissue kit (Qiagen, Germany) was 
performed according to the manufacturer’s instruction. The frozen tissues of 
approximately 25 mg were weighed and pulverized with liquid nitrogen using mortar 
and pestle before the samples were thawed and placed into a 2 ml microcentrifuge tube.  
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Figure 3.1 Tissue sample collection of M.rosenbergii 
 
Then, 180 μL of Buffer ATL and 20 μL of proteinase K were added to the tube. The 
mixture was mixed well through vortexing and followed by incubation at 56°C for 3 
hours.  To obtain RNA-free genomic DNA, 4 μL of RNase A (100 mg/ml) was added. 
They were mixed and incubated at room temperature for 2 minutes. The homogenate 
was vortexed occasionally during incubation. Thereafter, 200 μL of Buffer AL was 
added and mixed thoroughly by vortexing. Then, 200 μL of ethanol (96 -100%) was 
added to the lysate and mixed by vortexing. The mixture was pipetted into a DNeasy 
Mini spin column placed in a 2 ml collection tube and was centrifuged at 6000 x g for 1 
minute. The flow-through and collection tube was discarded. The DNeasy Mini spin 
column was placed in a new 2 ml collection tube and 500 μL of Buffer AW1 was added 
into it and was centrifuged at 6000 x g for 1 minute. The flow-through and collection 
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tube was discarded. The DNeasy Mini spin column was placed again in a new 2 ml 
collection tube and 500 μL of Buffer AW2 was added into it and was centrifuged at 
20,000 x g for 3 minutes to dry the DNeasy membrane. Later, the filtrate and collection 
tube were discarded. The DNeasy Mini spin column was placed in a clean 1.5 ml 
microcentrifuge tube and 200 μL of Buffer AE was pipetted directly onto the DNeasy 
membrane. Incubated at room temperature for 1 minute and followed by centrifugation 
for 1 minute at 6000 x g for elution. The DNA solution was stored at -20
o
C. The purity 
and concentration of the DNA was measured using NanoDrop 1000 Spectrophotometer 
(ThermoScientific, USA) and only samples with A260/A280 ratio of 1.8 to 2.0 were 
used for further analysis. 
 
3.3 Total RNA extraction 
Total RNA extraction using TRIzol reagent (Invitrogen, Carlsband, CA, USA) 
was performed according to the manufacturer’s instructions. The frozen target tissues of 
approximately 50 mg were weighed and pulverized with liquid nitrogen using mortar 
and pestle before the samples were thawed. The tissue samples were homogenized in 
1mL of TRIzol reagent in a 1.5 mL microcentrifuge tube. The homogenate was vortexed 
for 30 seconds and was incubated at room temperature for 5 minutes before proceeding. 
A 200 μL aliquot of chloroform was added to the 1.5 mL microcentrifuge tube 
containing homogenate and the mixture was shaken vigorously for 15 seconds. Then the 
mixture was incubated at room temperature for 3 minutes and followed by centrifugation 
at 12000 x g, 4°C for 15 minutes. After that, the supernatant was transferred to a clean 
1.5 ml microcentrifuge tube containing 500 μL of ice-cold isopropanol and mixed well 
by inverting the tube for a few times. The mixture was then incubated at room 
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temperature for 10 minutes and followed by centrifugation at 12000 x g, 4°C for 10 
minutes where the resulting supernatant was carefully decanted.  A total of 1 mL of 75% 
ice-cold ethanol was then added to the pellet and the tube was inverted gently several 
times to wash the RNA. The tube was spun at 7500 x g, 4°C for 5 minutes. The ethanol 
was aspirated carefully using a sequencing pipette tip. The tube was inverted on clean 
absorbent paper and the pellet was left to air-dry for 10 minutes. Finally, the RNA pellet 
was dissolved in 50 μL of DEPC-treated water and stored at -80oC. The purity and 
concentration of the RNA was measured using NanoDrop 1000 Spectrophotometer 
(ThermoScientific, USA) and only samples with A260/A280 ratio of 1.8 to 2.0 were 
used for further analysis. 
 
3.4 DNase treatment 
RNA samples were treated with Deoxyribonuclease (DNase) I (5Prime, 
Germany) before being subjected to downstream processes. The amount of each reagent 
used for the DNase treatment is shown in Table 3.1. The mixture was then incubated at 
room temperature for 10 minutes. The DNase- treated RNA sample was cleaned up by 
an isopropanol precipitation. 200 μL of isopropanol was added to the DNase- treated 
RNA sample and followed by centrifugation at 15,000 x g, 4°C for 20 minutes. 
Supernatant was decanted carefully without disturbing the pellet. The pellet was washed 
with 1 ml of 75% ethanol and followed by centrifugation at 15,000 x g, 4°C for 10 
minutes. The ethanol was aspirated carefully using a sequencing pipette tip. The tube 
was inverted on clean absorbent paper and pellet was left to air-dry for 10 minutes. 
Finally, the RNA pellet was dissolved in 50 μL of DEPC-treated water and stored at -
80
o
C. 
 26 
Table 3.1 DNase I Digestion Mixture 
 
Reagent/ Solution Volume (μL) 
RNA sample 80 
Buffer DNase Digestion Buffer 10 
DNase I stock solution 2.5 
DEPC-treated water Top up to 100 μL 
 
 
3.5 Preparation of small RNA library 
For preparation of small RNA library, total RNA (Section 3.3) was isolated from 
the gill and hepatopancreas tissues from a pool of adult M.rosenbergii. Thereafter, the 
total RNA was treated with DNase (Section 3.4). Approximately 20 µg of DNase treated 
total RNA representing each tissue was dissolved in DEPC-treated water at a 
concentration of not less than 750 ng/µl and stored at -80
o
C prior to small RNA 
sequencing at the Beijing Genomic Institute, Shenzhen, China (BGI, Shenzhen). The 
integrity of the RNA was measured by using Bioanalyzer (Agilent Technologies, USA). 
Only RNA samples with high integrity (RIN >7) were used for further analysis. 
 
3.6 Illumina deep sequencing 
Two small RNA libraries of gill and hepatopancreas tissues were sequenced 
using standard methods at BGI, Shenzhen. 10ug of total RNA were size fractionated by 
Novex 15% TBE-Urea gel (Invitrogen) and RNA fragments of length between 18 to 30 
nucleotides were isolated. The RNA fragments were then ligated with 5' RNA adapter 
(5'-GUUCAGAGUUCUACAGUCCGACGAUC-3’) (Illumina, San Diego, CA, USA) 
and 3' RNA adapter (5'-pUCGUAUGCCGUCUUCUGCUUGUidT-3’; p: phosphate; 
idT: inverted deoxythymidine) (Illumina, San Diego, CA, USA) to their 5’ and 3’ 
termini. Thereafter, the RNA fragments with adapter in both ends were amplified by RT-
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PCR using adaptor primers (Illumina, San Diego, CA, USA) for 17 cycles. Fragments of 
about 90 bp (small RNA + adaptor derived cDNA) were isolated from Novex 6% TBE 
gel (Invitrogen) of RT-PCR products. After quantification, the purified cDNA was used 
directly for cluster generation and sequencing analysis using the HiSeq 2000 Illumina 
Genome Analyzer (Illumina, San Diego, CA, USA).  Thereafter, the image files 
generated by the sequencer, Illumina Genome Analyzer (Illumina, San Diego, CA, USA) 
were processed using open source Firecrest and Bustard applications (Illumina, San 
Diego, CA, USA) to produce digital-quality data (36 nucleotide).  
 
 
3.7 In silico analysis and small RNA annotation  
Each 36 nucleotide end read (raw dataset) obtained from Illumina Genome 
Analyzer (Illumina, San Diego, CA, USA) was processed with a bioinformatics’ pipeline 
developed at Beijing Genome Institution, BGI (unpublished) as follows: 1) filtering low 
quality reads, 2) trimming of adaptor sequence at the 3’ end, 3) cleaning up 5’ end 
adaptor contaminants formed by adaptor and adaptor ligation, 4) remove sequences with 
poly-A tail, 5) filtering of reads smaller than 18 nucleotides to obtained high quality 
clean reads (18 to 30 nucleotides in length) and draw size distribution. Thereafter, the 
clean reads (18 to 30 nucleotide) were further subjected to computational analysis.  
The clean reads (18 to 30 nucleotides in length) that mapped perfectly to the de 
novo transcriptome of M. rosenbergii (Transcriptome Shotgun Assembly (TSA) 
Sequence archive under the accession number: TSA JP351514-JP355722) which was 
assembled using SOAP2 (Li et al., 2009) were further annotated and classified into 
different categories including rRNA, tRNA, snRNA, snoRNA and repeat associated 
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sequences by aligning the small RNAs against the known non-coding RNAs obtained 
from NCBI non-coding genbank database (URL:http://www.ncbi.nlm.nih.gov/genbank/) 
and Rfam 10.0 (Gardner et al., 2009; Griffiths-Jones et al., 2005; Griffiths-Jones et al., 
2003) with NCBI BLASTN (Altschul et al., 1997) and RepeatMasker (Smit et al., 1996-
2010; URL: http://www.repeatmasker.org). Those sequences were discarded assuming 
that they represent degradation and other undesired products. 
The filtered sequences were aligned with NCBI BLASTN (Altschul et al., 1997) 
to a non-redundant reference set of all animal miRNAs from miRBase 15.0 (Griffiths-
Jones, 2004; Griffiths-Jones et al., 2006; Griffiths-Jones et al., 2008; Kozomara and 
Griffiths-Jones, 2011) by allowing at most two mismatches outside of the seed region. 
Small RNAs that matched known miRNAs of other animal species were assumed to 
correspond to conserved miRNA orthologs in M.rosenbergii. The orthologous miRNA 
sequences were assigned to their respective miRNA families based on the similarity 
(identity score) to any existing miRNA family members. Pre-miRNAs were predicted 
based on the presence of hairpin structures identified by using MIREAP (Liu et al., 
2010b) to scan through the de novo transcriptome of M.rosenbergii using default 
settings. The RNA secondary structures of pre-miRNA hairpin were drawn using 
RNAfold (Hofacker, 2009). Candidates corresponding to known miRNAs from miRBase 
15.0 (Griffiths-Jones, 2004; Griffiths-Jones et al., 2006; Griffiths-Jones et al., 2008, 
Kozomara and Griffiths-Jones, 2011) and supported by at least two reads of mature 
sequences were considered real miRNA genes (Liu et al., 2010b).  
In order to predict novel miRNA candidates from the two small RNA libraries, 
the following criteria were used: (1) small RNA annotated as orthologous miRNAs or as 
other classes of noncoding RNA were excluded; (2) an individual locus had to be 
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supported by a minimum of five independent sequence reads originating from at least 
one small RNA library to be considered for further analysis; (3) the loci lacking hairpin-
like RNA secondary structures with the mature sequences within a stem were eliminated 
(Liu et al., 2010b).  
The flanking region of the unannotated reads that perfectly mapped to the de 
novo trancriptome by SOAP2 (Li et al., 2009) were extracted and analyzed by MIREAP 
under default settings. MIREAP is a computational tool designed to identify known and 
novel miRNA candidates based on the prediction of hairpin structures within data from 
deeply sequenced small RNA libraries. This software which was downloaded from 
https://sourceforge.net/projects/mireap, takes into account miRNA biogenesis, 
sequencing depth and structural features to improve the sensitivity and specificity of 
miRNA identification. The RNA secondary structures of pre-miRNA hairpin were 
drawn using RNAfold (Hofacker, 2009). Stem-loop hairpins were considered distinctive 
only when they fulfilled three criteria: (1) mature miRNAs are present in one arm of the 
hairpin precursor; (2) absence of large internal loops or bulges (n< 5); (3) a minimal free 
energy of hybridization lower than -20 kcal/mol (Chen et al., 2009). Pseudo-pre-miRNA 
sequences were removed by stepwise use of the following filters: NCBI BLASTX 
(Altschul et al., 1997) against Non-redundant NCBI database (Nr) (URL: 
http://www.ncbi.nlm.nih.gov/genbank/) and Swiss-Prot (The UniProt Consortium, 2010) 
to exclude transcripts similar to any known, putative, and hypothetical proteins (E-value 
< 0.01); EMBOSS program getORF to exclude possible open reading frame (ORF) (Rice 
et al., 2000) (default parameters); ESTScan to detect potential coding regions based on 
the codon bias of coding regions derived from the de novo transcriptome of 
M.rosenbergii (Iseli et al., 1999) (default parameters); INFERNAL program (Nawrocki 
 30 
et. al., 2009) cmsearch against the Rfam 10.0 database to remove homologs of known 
non-coding RNA based on sequence similarity and secondary structure (Gardner et al., 
2009; Griffiths-Jones et al., 2005; Griffiths-Jones et al., 2003) (E-value <0.01) and 
tRNAscan-SE to remove tRNA sequences (Lowe et al., 1997). 
 
3.8 MicroRNA target gene prediction and enrichment analysis 
For miRNA target prediction, a support vector machine (SVM) developed at 
Beijing Genomic Institute, BGI (unpublished) was trained with experimentally tested 
target and miRNA of Drosophila melanogaster and Homo sapiens to determine the 
optimal parameters to be used in RNAhybrid 2.2 (Kruger et al., 2006). These values 
were: helix constraint: 2 to 8; internal loop size: 5; bulge loop size: 5 and maximum 
target length: 100,000. RNAhybrid predicts potential binding sites for miRNAs in large 
target RNAs using the principle of finding the most energetically favourable 
hybridization site between two sequences (Kruger et al., 2006). The potential targets of 
the miRNA were matched to the de novo transcriptome of M.rosenbergii and were used 
for the following annotation: NCBI BLASTX (Altschul et al., 1997) against Non-
redundant NCBI database (Nr) (URL: http://www.ncbi.nlm.nih.gov/genbank/) / Swiss-
Prot (The UniProt Consortium, 2010)/ Kyoto Encyclopedia of Genes and Genomes 
(KEGG) (Kanehisa et al., 2002, URL: http://www.genome.jp/kegg)/Clusters of 
Orthologous Groups of proteins (COG) (Tatutsov et al., 2003; URL: 
http://www.ncbi.nlm.nih.gov/COG) to annotate transcripts similar to any known, 
putative, and hypothetical proteins (E-value < 10
-5
). Functional annotation using gene 
ontology (GO) was performed using BLAST2GO (Ashburner et al., 2000). For 
quantification and evaluation of target gene expression, RPKM (reads per kilobase per 
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million reads) and Bejamini and Hochberg, (1995) false discovery rate (FDR< 0.001) 
(Wang et al., 2010) were used respectively. The false discovery rate (FDR) was applied 
to evaluate the significance of gene expression difference. A statistical procedure known 
as enrichment (over-representation) analysis was used to narrow down potential miRNA 
targets (Gusev, 2008). The pathway enrichment analysis was based on the association of 
targets for individual miRNAs with pathways annotated in the KEGG database 
(Kanehisa et al., 2002, URL: http://www.genome.jp/kegg). The Fisher’s exact test with 
Bonferroni correction (p-value <0.05) for multiple testing was applied to determine the 
pathway enrichment for target genes (false discovery rate, FDR< 0.001) of each co-
expressed miRNA [(fold change (log2) >1 or fold change (log2) >-1 and p-value <0.05)] 
between gill and hepatopancreas tissues. The statistical analysis of Fisher’s exact test 
with Bonferroni correction (p-value <0.05) was computed using IDEG6 (Romualdi et 
al., 2003). The parameters considered in this test are: (1) Total number of miRNA target 
genes; (2) Total number of differentially expressed miRNA target genes; (3) Number of 
miRNA target genes associated with a specific pathway; (4) Number of differentially 
expressed miRNA target genes associated with a specific pathway. Inverse correlation 
analysis of the miRNA and their target gene (mRNA) expression profiles was carried out 
for each enriched pathway using the lists of differentially expressed miRNAs (fold 
change (log2) >1 or fold change (log2) >-1 and p-value <0.05) and mRNAs (false 
discovery rate, FDR<0.001) between gill and hepatopancreas tissues. 
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3.9 Stastistical tests for differential expression  
3.9.1 Normalization of the expression data 
The expression data for each small RNA library was standardized according to the 
equation below (Zhu et al., 2010):  
 
Xstd 
 
= Xexpressed  / Xtotal   × 10
6
        
         
(1) 
 
Whereby Xexpressed 
 
indicates the total number of reads for a particular miRNA in gill and 
Xtotal  indicates the total number of clean reads in G, where G is the small RNA library 
from gill tissue. 
 
Ystd 
 
= Yexpressed  / Ytotal  × 10
6
         
        
(2) 
 
Whereby Yexpressed 
 
indicates the total number of reads for a particular miRNA in 
hepatopancreas and Ytotal  indicates the total number of clean reads in H, where H is the 
small RNA library from hepatopancreas tissue. 
 
3.9.2 Fold change 
Fold change = log2 (Ystd 
  
/ Xstd  )                 (3) 
 
Whereby Xstd indicates the normalized expression for a particular miRNA in gill, which 
is calculated from equation (1) and Ystd indicates the normalized expression for a 
particular miRNA in hepatopancreas, which is calculated from equation (2) 
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3.9.3 Audic-Claverie 
The statistical test of Audic-Claverie, (1997) which is based on Poisson statistics, was 
used to analyze data from the two different libraries. This model test has been previously 
applied to serial analysis of gene expression (SAGE) (Velculescu et al. 1995) and RNA-
Seq (Sultan et al., 2008) expression data. The statistic is calculated according to equation 
below: 
 
                   (4) 
 
where x indicates total number of reads for a particular miRNA in gill, y indicates the 
total number of reads for a particular miRNA in hepatopancreas. N1 and N2  represent the 
total numbers of clean reads in G and H respectively. The p-value indicates the 
probability of obtaining y count in H given x counts in G.  
 
In this study significant signature was used as follows: 
** fold change (log2 ) >1 or fold change (log2) <-1 and p-value<0.01  
*   fold change (log2) >1 or fold change (log2) <-1 and 0.01 <= p-value<0.05 
 
3.10 MicroRNA dot-blot 
3.10.1 Preparation of microRNA oligo dot-blot nylon membrane  
The miRNA dot-blot method used in this study was modified from Wang and 
Cheng (2008). A library of 47 antisense oligodeoxynucleotides (50 nmol scale, 100 μM, 
20 to 22 nucleotides) of M.rosenbergii‘s mature miRNA, mature-star miRNA (miRNA*) 
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and other small RNA sequences were synthesized (Table 3.2). Each of the antisense 
oligonucleotides, 10 μM was dotted in duplicate in the form of 96-well. The negative 
control (non probe control) used was nuclease free-water. The positive control used was 
antisense oligonucleotides of beta-actin gene, 5’GAG TTG TAT GTG GTC TCG TGG 
A 3’ (22 nucleotides). The positive control was dotted on additional strip of nylon 
membrane in serial concentration of 10 μM, 8 μM, 6 μM¸ 4 μM¸ 2 μM and 0 μM. 
Hybond –XL nylon membrane (Amersham, UK) was cut to the exact size 8.5 cm 
(width) × 12 cm (length), of the dot-blot manifold. The membrane was placed in wetting 
buffer (0.4 M Tris-HCl, pH 7.5) and soaked for 5 minutes. The wet membrane was 
placed on the manifold. The manifold was cleaned and rinsed with Millipore water prior 
to use. The oligos were diluted in TE buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA) to 
10 µM in a 96-well plate to make duplicate dot blots. Thereafter, equal volume (20 µl) of 
2 × denature buffer was added to the diluted oligos, mixed well, and incubated for 10 
minutes at room temperature. Later, 40 µl of nuclease free-water and 150 µl of dilution 
buffer (0.1 × SSC, 0.125 N NaOH) were added to the diluted oligos (samples) on ice. A 
100 µl of samples was loaded into the manifold. A light suction was applied to the 
manifold until the loading buffer is drawn through the wells. A 100 µl of washing buffer 
(0.5 N NaCl, 0.5 M Tris-HCl, pH 7.5) was added to each well and a light suction was 
applied to neutralize and to wash the membrane. This washing step was carried out 
twice. After that, the membrane was removed from the manifold and the wet membrane 
was placed on a piece of whatmann paper. The oligos were fixed to the membrane by 
UV-crosslinking at 120 mJ/cm
2
 for 1 minute. The membrane was air-dried, labeled with 
pencil, sandwiched with two whatmann paper and stored at 4
o
C in a plastic bag until 
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needed. The dot blot apparatus was washed and rinsed with distilled water before the 
next run. 
 
Table 3.2 Antisense oligonucleotides for miRNA dot-blot 
 
Location on nylon 
membrane 
miRNAs miRNA antisense sequences (5’ to 3’) 
A1; A7 
 
miR-125_G 
 
ACAAGAAAGGGTCTCAGGGA 
 
A2; A8 
 
miR-125_H 
 
TCACAAGAAAGGGTCTCAGGGA 
 
A3; A9 
 
miR-750_H 
 
AGCTGGAAGAGTTAGATCTGG 
 
A4; A10 
 
G-m0003 
 
CTTAAGTAATGCCTACAGTGCA 
 
A5; A11 G-m0005 
 
CTGTTTCGCCGTGTTTAGTACT 
 
A6; A12 
 
G-m0006 
 
TAGTACTAAACACGGCGAAACAG 
 
B1; B7 
 
UCR 
 
AACATACCAGTTTGCAGCCCTG 
 
B2; B8 
 
UCR CCTCCTCCTCTCCCTCTCCCT 
 
B3; B9 
 
G-m0009 CAACCTCCCACCGCAGACCCCA 
 
B4; B10 
 
G-m0011/ 
H-m0027 
 
ACATACCAAATTGCAGCCCTCT 
 
B5; B11 G-m0007 TTAAGTAATGCCTACAGTGTA 
 
B6; B12 
 
G-m0019 TTAAGTAATGCCTACAGTGCA 
 
C1; C7 
 
G-m0008/ 
H-m0016 
 
AAACATACCAAATTGCAGCCCT 
 
C2; C8 
 
G-m0004 ACATATGGGGCTTCAACAGAGT 
 
C3; C9 
 
G-m0004* CACTCCAGTCAAGCACCAAT 
 
C4; C10 
 
G-m0002/ 
H-m0009 
 
ATGCCTGAGCACCTTGCTTGT 
 
C5; C11 UCR GATGCTACTGTGTCCTGTTAGA 
 
C6; C12 
 
UCR CAATTCGGTGTTCGCTTCACA 
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D1; D7 
 
UCR ACTCCGTGACCGCTGGTTTGTT 
 
D2; D8 
 
UMR 
 
TTGACAAAACCAGCCGAAAACGTA 
 
D3; D9 
 
H-m0012 
 
CTTAAGTAATGCCTACAGTGCA 
 
D4; D10 UMR 
 
TCTCTCTCCACTTCTTGAACA 
 
D5; D11 H-m0019 
 
TATCCCTCGGATCTTAAAGACA 
 
D6; D12 
 
UMR 
 
GATTGTAAAGTACAGCCTTACAGA 
 
E1; E7 
 
UMR TGCCCGTGAAGACGATAATAACGA 
 
E2; E8 
 
H-m0020 
 
ACATCACCCTGTCTCAATCTCCA 
 
E3; E9 
 
H-m0020* ACGGCCTGTGAATTGGTGGAGGTATA 
 
E4; E10 
 
H-m0021 
 
GCGAAATCCGTCCTGCTCGAAAG 
 
E5; E11 H-m0022 
 
GAAACTGCTGCTCTTCCGCTCGTA 
 
E6; E12 
 
UMR 
 
GAACGTCACTCTCATCAGAAG 
 
F1; F7 
 
UCR 
 
AAAACCCTCTCAAACCTCCTA 
 
F2; F8 
 
UCR 
 
CTCAACAAGTCTTGGGTC 
 
F3; F9 
 
H-m0025 
 
CAACTGTAGTCTAGTCGCGTG 
 
F4; F10 
 
H-m0034 
 
AAAGAAGACCAGATTTAGAGACA 
 
F5; F11 H-m0030 
 
AGAAACTAAAGCTACAGGTTCT 
 
F6; F12 
 
H-m0041 
 
CTTGAGTACCCCACAGCAATCCTA 
 
G1; G7 
 
H-m0044 
 
CATAAACCGGCATGTTCTTA 
 
G2; G8 
 
UCR 
 
ATGCCATTTCGCCACACTATGGA 
 
G3; G9 
 
UMR CTTTCCAAATCATCTCTTGATA 
 
G4; G10 
 
UMR AGTAAATCAACAGATAATAAACCAA 
 
G5; G11 H-m0033 TTTCCACCAAATACAGTTCAA 
 
G6; G12 
 
UCR GCTAGCCAAGAGCTCTACCCA 
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H1; H7 
 
UCR AACATACCAAATTGCAGCCCCC 
 
H2; H8 
 
UMR CTAGAGGGCTGCAAATTGGTAT 
 
H3; H9 UMR TACCAAATTGCAGCCCTCT 
 
H4; H10 
 
UMR ACATTGCTAGGTACCTAGTGCA 
 
H5; H11 UMR AGCCAGTGCCCCAATTTGTGCTCA 
 
H6; H12 Non probe control Nuclease free water 
 
 
3.10.2 Total RNA extraction and enrichment of microRNA 
A100 µg of total RNA (Section 3.3) with concentration of 1 µg/µl was used for 
enrichment of microRNA. The total RNAs were preheated at 80°C for 3 minutes and 
cooled on ice for 2 minutes. The RNA was then pipetted to the top of Amicon Ultra-0.5 
ml centrifugal filter, 100 kDa (Milipore, USA) and followed by centrifugation at 14000 
× g, 4°C for 10 minutes to obtain enriched microRNAs. Save the eluate containing the 
small molecular weight RNAs in the collection tube. A NanoDrop 1000 
Spectrophotometer (Thermo Fisher Scientific, USA) was used to obtain the 
concentration of the small RNAs. The samples were stored at -80°C until needed for 
labeling. 
 
3.10.3 RNA labeling 
A 500 ng of enriched small RNA derived from 100 µg total RNA was labeled 
with 32P-αATP. At room temperature, tailing reaction reagent was added to each 
enriched small RNA sample in the order shown in Table 3.3 and mixture was mixed well 
followed by incubation at 37°C for 3 to 4 hours. 
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Table 3.3 RNA labeling 
 
Components Volume (µl)  Final 
concentration 
5 × poly (A) polymerase reaction buffer (USB, 
USA) 
5 1 × 
Enriched small RNA 16.5 500 ng 
32P-αATP (ARC, USA) 2.5 0.05mCi 
Yeast Poly(A) Polymerase (USB, USA) 0.5 600U 
RNasin (Promega, USA) 0.5 20-40 U 
Total 25  
 
 
3.10.4 Post-tailing clean up  
A G25 Sephadex Gravity column was used for post-tailing miRNA clean-up. 
Pasteur pipettes plugged with glass wool was packed with silicon. The pre-packed 
column was stored under TE buffer in a tube. Prior to usage, the TE buffer was allowed 
to run through the column twice. When the TE buffer enters the column matrix, labeled 
probes mixed with blue dextran-orange (1:1) (Sigma Aldrich, USA) was added into the 
column. The blue fraction which contained the labeled probes was collected and checked 
with Geiger counter. 
 
3.10.5 Prehybridzation and hybridization 
The dotted nylon membrane was pre-wetted with wetting buffer before insertion 
into hybridization bottles. The membrane was prehybridized with 10 ml of Ultrasensitive 
Hybridization Buffer (Ambion, USA) at 42°C for 1 hour. Thereafter, hybridization was 
carried out with 10 ml of Ultrasensitive Hybridization Buffer and purified labeled probes 
at 42°C for 16 hours. Following hybridization, the membranes were washed with 20 ml 
of 2 x SSC/0.5% SDS at 42°C for 10 minutes (twice), 20 ml of 1 x SSC/0.5% SDS at 
42°C for 15 minutes and 20 ml of 0.5 x SSC/0.5% SDS at 42°C for 10 minutes. The 
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membrane was then wrapped with cling film and inserted into a cassette. X-ray film 
(Kodak, Japan) was inserted into the cassette in dark room. The cassette was then stored 
in -80°C freezer for three days. After exposure, the X-Ray film was developed in the 
dark room. The developed film was hung to air-dry. Image captured by the film was 
scanned. 
 
3.11 Reverse transcription 
First strand cDNA was synthesized using a Reverse Transcription System kit 
(Promega, USA). The amount of each reverse transcription reagent used is shown in 
Table 3.4. The tube containing cDNA synthesis mixture was placed in a thermal cycler. 
The reactions were incubated at 25° for 10 minutes followed by one cycle of 42°C for 15 
minutes, 95°C for 5 minutes and 4°C for 5 minutes.  
 
Table 3.4 Reverse Transcription Mixture 
 
Component Final Volume Final concentration 
Magnesium chloride (MgCl2), 25mM 4μL 5mM 
Reverse tansciption 10× buffer 2μL 1x 
dNTP mixture, 10mM 2μL 1mM 
Recombinant RNasin ribonuclease inhibitor 0.5μL 1 Unit /μL 
AMV reverse transciptase 0.6μL 15 Unit /μL 
Random primer 1.0μL 0.5μg /μL 
RNA template 20ng - 
Nuclease- free water Top up to 20μL  
 
 
3.12 Validation of miRNA expression by semi quantitative RT-PCR and sequencing 
DNase (5Prime, Germany) treated total RNA of gill and hepatopancreas was 
reverse-transcribed to cDNA using a Reverse Transcription System kit (Promega, USA) 
(Section 3.11). For each 25 μL of PCR reaction, 20 ng of cDNA or DNA was used as 
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template with 1.5 μL of 25 mM magnesium chloride, 5.0 μL of 5x PCR reaction buffer, 
0.5 μL of 10 mM dNTP mix, 0.5 μL of each miRNA-specific forward and reverse 
primers (Table 3.5), 0.125 μL of GoTaq DNA polymerase (Promega, USA) and topped 
up to 25 μL with nuclease-free water. The reactions were incubated at 95°C for 3 
minutes, followed by 29 repeated cycles of 95°C for 30 seconds, 60°C for 30 seconds, 
and 72°C for 30 seconds. The final cycle was followed by extension at 72°C for 5 
minutes. The positive control used was beta-actin (forward primer sequence: 5’ TCC 
ACG AGA CCA CCT ACA AC 3’; reverse primer sequence: 5’ GAG GGC AGT GAT 
TTC CTT CT 3’) and a template free negative control of nuclease-free water was 
included in each PCR run. Each miRNA was analyzed in duplicate. The PCR products 
were separated using 2% agarose gel at 78V, 150mA for about 45 minutes and the 
sequence determined using a conventional DNA sequencing service (Figure 4.3). 
 
Table 3.5 Primers for putative M.rosenbergii miRNA precursors 
 
Putative 
M.rosenbergii 
miRNA precursors 
 
miRNA-specific forward and reverse primer Expected 
size of 
PCR 
product 
mir-125_G, 
mir-125_H, 
G-m0002, 
H-m0009 
 
125F: 5'-CAGAGAGCTCGCCATCCAT -3' 
125R: 5'-CTGAATCAATCTGCCCATGT-3' 
162bp 
mir-750_H 750F: 5'-AGCTGACTCCCTGGACAAGA3' 
750R: 5'-TTTCCTAAAGTCGCCTCGAA-3' 
297bp 
 
 
 
3.13 PCR product purification 
NucleoSpin Extract II (Macherey-Nagel, Germany) was used for PCR clean-up 
according to manufacturer’s instruction. One volume of PCR product was mixed with 2 
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volumes of Buffer NT. The mixture was carefully pipetted into the NucleoSpin Extract 
II column which was placed into a collection tube and was then centrifuged for 1 minute 
at 11,000 × g. The flow-through was discarded and the NucleoSpin Extract II column 
was placed back into the collection tube. After that, 700 μL of Buffer NT3 was added to 
the NucleoSpin Extract II column. The flow-through was discarded and the NucleoSpin 
Extract II column was placed back into the collection tube. The tube with the 
NucleoSpin Extract II column was centrifuged again at 11,000 × g for 2 minutes to 
remove residual of Buffer NT3. The NucleoSpin Extract II column was placed in a 
clean, 1.5 ml microcentrifuge tube. Thereafter, 30 μL of pre-warmed Buffer NE was 
pipetted directly onto the membrane and was incubated at room temperature for 1 
minute. Finally, the column was centrifuged at 11,000 × g for 1 minute to collect the 
purified PCR products.  
  
3.14 Validation of miRNA expression by stem-loop quantitative real-time PCR 
A Custom Taqman MicroRNA Assay (Applied Biosystems, Foster City, CA, 
P/N: 4398987) was designed based on small RNA sequences of M.rosenbergii. The 
expression of mature miRNAs was assayed using the Custom Taqman MicroRNA Assay 
(Table 3.6) specific for miR-125 (Assay ID: CSS061K), miR-750 (Assay ID: CST947S), 
G-m0002/H-m0009 (Assay ID: CSVl3D0), G-m0005 (Assay ID: CSRR8XB), G-
m0008/H-m0016 (Assay ID: CSS063J), G-m0011/H-m0027 (Assay ID: CST949R) and 
G-m0015 (Assay ID: CSV13FZ)  on five types of tissues of M.rosenbergii i.e. 
hepatopancreas, gill, muscle, pleopod, and eye.  Each sample was analyzed in triplicate. 
DNase (5Prime, Germany) treated total RNA was reverse transcribed using the TaqMan 
MicroRNA Reverse Transcription Kit (P/N 4366596) with respective miRNA-specific 
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stem-loop RT primer (Applied Biosystems, Foster City, CA). The 15.0 μL of reverse 
transcription (RT) reaction included: 1.0 μL of DNase treated total RNA (50 ng/μL), 1.5 
μL of 10x  RT Buffer,  1.0 μL of  50 U/μL MultiScribe Reverse Transcriptase, 0.15 μL  
of 100mM dNTPs, 0.19 μL of  20 U/μL RNase-inhibitor, 3.0 μL of speciﬁc RT primer 
and 8.16 μL of nuclease-free water. The reactions were incubated at 16°C for 30 min, 
42°C for 30 min, 85°C for 5 min and hold at 4°C. Real-time PCR was performed using 
the standard Taqman MicroRNA Assays protocol on a 7500 Real-Time PCR (Applied 
Biosystem, Foster City, CA). The 10 µL PCR included 0.66 µL of RT product, 5 µL of 2 
x Taqman Universal PCR Master Mix, No AmpErase UNG (P/N: 4324018), 0.5 μL of 
20 x Taqman Small RNA Assay and 3.84 µL of nuclease-free water. The reactions were 
incubated at 95°C for 10 min followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. 
The level of miRNA expression was measured using Ct (threshold cycle) at fixed 
threshold level of 0.2. Outlier (>2 standard deviations) was discarded from subsequent 
analysis. Comparative Ct method was used to determine miRNA expression levels 
(Livak et al., 2001; Schmittgen et al., 2008). The Delta Ct was calculated by subtracting 
the Ct of reference gene (snRNA) from the Ct of the miRNA of interest. The Delta Delta 
Ct was calculated by subtracting the Delta Ct of the calibrator (gill) from the Delta Ct of 
each sample. Fold change was generated using the equation 2(-Delta Delta Ct) (Livak et 
al., 2001; Schmittgen et al., 2008). The Custom Taqman MicroRNA Assay for snRNA 
(Assay ID: CSPACl9) was used to normalize the relative abundance of miRNA.  
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Table 3.6 Custom taqman miRNA assay 
 
Assay_id miRNAs Target sequences (5’to 3’) 
CSS061K miR-125  TCCCTGAGACCCTTTCTTGT 
CST947S miR-750  CCAGATCTAACTCTTCCAGCT 
CSVI3D0 G-m0002/H-m0009  ACAAGCAAGGTGCTCAGGCAT 
CSRR8XB G-m0005 AGUACUAAACACGGCGAAACAG 
CSS063J G-m0008/H-m0016 AGGGCUGCAAUUUGGUAUGUUU 
CST949R G-m0011/H-m0027 AGAGGGCUGCAAUUUGGUAUGU 
CSVI3FZ G-m0015 GAACGAGACGGCGAGAGAGUGA 
CSPACI9 snRNA TTGGAACGATACAGAGAAGATTAGCAT 
 
 
3.15 Pearson correlation coefficient 
A correlation of miRNA deep sequencing counts and stem-loop quantitative real-
time PCR was assessed with Pearson correlation coefficient, r to determine the 
agreement between both platforms. A Pearson correlation scatter plot of (logarithmized) 
normalized sequencing counts (deep sequencing data) against –DeltaCt values (qRT-
PCR) was drawn. The Ct (cycle threshold) is deﬁned as the PCR cycle at which the 
ﬂuorescent signal cross the threshold. Hence, Ct values are inversely related to the 
logarithmized amount of target nucleic acid in the sample. Conversion of the Ct values 
by multiplication with (-1) results in negative Ct values which is proportional to the 
logarithmized amount of target nucleic acid. 
 
3.16 IHHNV challenge test on M.rosenbergii and qRT-PCR of the miRNA 
expression 
The sub-adult prawns (average body weight 10 g) were obtained from Bandar Sri 
Sedayan, Negeri Sembilan, Malaysia. The prawns were maintained in flat-bottomed 
glass tanks with aerated and filtered water at 28°C +/- 1°C in the laboratory (4 sub-adult 
prawns per tank). All prawns (72 sub-adult prawns) were acclimatized for a week before 
 44 
challenged with infectious hypodermal and hematopoietic necrosis virus (IHHNV). The 
IHHNV infected prawn pleopod tissues were homogenized in PBS solution. Each prawn 
was injected with crude extract of virus (IHHNV) in PBS solution (100 μL per 10 g 
prawn). The tissues of the sub-adult prawn were collected before injection, 0 hrs 
(control) and post-injection of 3 hrs, 6 hrs, 9hrs, 24 hrs, 48 hrs. These samples were 
frozen in liquid nitrogen and stored at -80°C. Total RNA were extracted from the 
hepatopancreas tissues using Trizol (Section 3.3) for each time point. The expression of 
mature miRNAs at various time point of infection was assayed using the Custom 
Taqman MicroRNA Assay (Table 3.6) (Applied Biosystems, Foster City, CA, P/N: 
4398987) specific for miR-125 (Assay ID: CSS061K), miR-750 (Assay ID: CST947S), 
G-m0002/H-m0009 (Assay ID: CSVl3D0), G-m0005 (Assay ID: CSRR8XB), G-
m0008/H-m0016 (Assay ID: CSS063J), G-m0011/H-m0027 (Assay ID: CST949R) and 
G-m0015 (Assay ID: CSV13FZ). Each sample was analyzed in triplicate. DNase 
(5Prime, Germany) treated total RNA was reverse transcribed using the TaqMan 
MicroRNA Reverse Transcription Kit (P/N 4366596) with respective miRNA-specific 
stem-loop RT primer (Applied Biosystems, Foster City, CA). The 15.0 μL of reverse 
transcription (RT) reaction included: 1.0 μL of DNase treated total RNA (50 ng/μL), 1.5 
μL of 10x  RT Buffer,  1.0 μL of  50 U/μL MultiScribe Reverse Transcriptase, 0.15 μL  
of 100mM dNTPs, 0.19 μL of  20 U/μL RNase-inhibitor, 3.0 μL of speciﬁc RT primer 
and 8.16 μL of nuclease-free water. The reactions were incubated at 16°C for 30 min, 
42°C for 30 min, 85°C for 5 min and hold at 4°C. Real-time PCR was performed using 
the standard Taqman MicroRNA Assays protocol on a 7500 Real-Time PCR (Applied 
Biosystem, Foster City, CA). The 10 µL PCR included 0.66 µL of RT product, 5 µL of 2 
x Taqman Universal PCR Master Mix, No AmpErase UNG (P/N: 4324018), 0.5 μL of 
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20 x Taqman Small RNA Assay and 3.84 µL of nuclease-free water. The reactions were 
incubated at 95°C for 10 min followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. 
The level of miRNA expression was measured using Ct (threshold cycle) at fixed 
threshold level of 0.2. Outlier (>2 standard deviations) was discarded from subsequent 
analysis. Comparative Ct method was used to determine miRNA expression levels 
(Livak et al., 2001; Schmittgen et al., 2008). Fold change was generated using the 
equation 2^(-Delta Delta Ct) = [Ct(miRNA) – Ct(reference gene)] time x – [Ct(miRNA) – 
Ct(reference gene)] time 0 (Livak et al., 2001; Schmittgen et al., 2008). The Custom 
Taqman MicroRNA Assay for snRNA (Assay ID: CSPACl9) was used to normalize the 
relative abundance of miRNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
